カテゴリ： GlobalData, アメリカ, 企業調査

Medidata Solutions Inc (MDSO)-医療機器分野：企業M&A・提携分析

◆英語タイトル：Medidata Solutions Inc (MDSO) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA8011139
◆発行会社（調査会社）：GlobalData
◆発行日：2017年12月21日
◆ページ数：79
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Medidata Solutions Inc (Medidata) is a provider of cloud based solutions for life sciences sectors. It offers wide range of advanced tools for data & analytics, planning, data capture, study management, monitoring, payments, and platform services. The company offers technology and data analytics solutions, using secure cloud and hybrid cloud infrastructure. Medidata’s service portfolio includes implementation, configuration, data testing, and integration support, training, reporting and consultation services for clinical development process. The company offers its services to pharmaceutical, biotechnology and medical device companies, academic institutions, and contract research organizations. The company markets and sells its products through direct sales force, contract research organization and strategic partners in North America, Europe and Asia. Medidata is headquartered in New York, the US.

Medidata Solutions Inc (MDSO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Medidata Solutions Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Medidata Solutions Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Medidata Solutions Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Medidata Solutions Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Medidata Solutions Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Medidata Solutions Inc, Medical Equipment, Deal Details 12
Venture Financing 12
Syapse Raises USD30 Million in Series D Financing 12
Shyft Analytics Raises USD12.5 Million in Series B Venture Financing 14
Partnerships 15
Quartesian Enters into Licensing Agreement with Medidata Solutions 15
Medidata Expands Partnership with CytomX Therapeutics 16
Medidata Solutions Expands its Agreement with BeiGene 17
Medidata Solutions and Karyopharm Therapeutics Expand Partnership 18
Medidata Solutions Enters into Agreement with Forty Seven 19
Medidata Solutions Enters into Agreement with Memorial Sloan Kettering Cancer Center 20
Medidata Solutions Partners with C&R Research 21
Auris Medical Enters Into Agreement With Medidata Solutions 22
Veeva Systems Enters Into Technology Integration Agreement With Medidata Solutions 23
Debt Offering 24
Medidata Solutions Completes Private Placement Of Notes Due 2018 For US$287.5 Million 24
Medidata Solutions Inc – Key Competitors 25
Medidata Solutions Inc – Key Employees 26
Medidata Solutions Inc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 30
Strategy And Business Planning 30
Sep 27, 2017: Medidata Opens New, Larger London EMEA Headquarters 30
Feb 10, 2016: Celgene Expands Relationship with Medidata in Enterprise Clinical Trial Technology 31
Financial Announcements 32
Oct 26, 2017: Medidata Reports Record Third Quarter 2017 Results 32
Apr 26, 2017: Medidata Reports Record First Quarter 2017 Results 34
Feb 09, 2017: Medidata Reports Record Full-Year and Fourth Quarter 2016 Results 36
Oct 25, 2016: Medidata Reports Record Third Quarter 2016 Results 38
Jul 20, 2016: Medidata Reports Record Second Quarter 2016 Results 39
Apr 21, 2016: Medidata Reports Record First Quarter 2016 Results 40
Feb 10, 2016: Medidata Reports Full-Year and Fourth Quarter 2015 Results 42
Corporate Communications 43
Apr 26, 2016: Christian Hebenstreit Joins Medidata as Managing Director of EMEA, Driving Growth and Development Across the Region 43
Legal and Regulatory 44
Jan 06, 2016: DATATRAK Announces Settlement of Patent Litigation 44
Product News 45
Nov 28, 2017: Medidata Presenting at the 2017 Partnerships in Clinical Trials Europe Conference 45
Nov 07, 2017: Median Technologies to Present at Medidata NEXT Global 2017 to Discuss How New Technologies Can Optimize Image Management in Clinical Trials 46
Nov 18, 2016: Medidata Introduces eConnect Partner Program 47
Jul 18, 2016: Medidata Introduces New Payment Technology on its Unified Platform to Automate Reimbursements to Clinical Trial Sites 48
Feb 25, 2016: Medidata’s Cloud Technology Powers U.S. Government Research on Drug Development Costs 49
Jan 26, 2016: ONO PHARMACEUTICAL Selects Medidata to Power Clinical Trials Exploring Additional Cancer Indications for Immunotherapy Drug OPDIVO 50
Other Significant Developments 51
Dec 05, 2017: Medidata Expands Partnership with CytomX Therapeutics to Centralize Management of Regulated and Nonregulated Content 51
Nov 15, 2017: Medidata Selected by ICON to Evolve Image Management and Accelerate Research Goals for Sponsors and Sites During Clinical Trials 52
Nov 09, 2017: Medidata Introduces New Strategic Monitoring Suite to Ensure Sponsors and Sites Meet ICH E6 Guidelines 53
Oct 26, 2017: Horizon Pharma to Leverage Medidata Clinical Cloud and eTMF Solutions to Support its Business Transformation 54
Oct 05, 2017: Neurological-Focused pharmaceutical company, Lundbeck, Continues Use of Medidata Clinical Cloud with Multi-Year Partnership 55
Jul 24, 2017: Medidata Expands Partnership with BeiGene to use Medidata’s Patient Cloud ePRO Solution 56
Jul 20, 2017: “Nature Reviews Drug Discovery” Publishes New Findings on Trial Complexity Based Upon Benchmark Data from Medidata 57
Jul 13, 2017: Medidata Successfully Hosts Annual European NEXT Conference Series 58
Jul 12, 2017: Worldwide Clinical Trials Selects Medidata to Streamline Clinical Site Reimbursements Across the Globe 59
Jun 13, 2017: Chiltern and Medidata Mark 10-Year Anniversary Milestone in Bringing Cloud-based Technology to Clinical Development 60
May 24, 2017: CROS NT Announces Extended Partnership With Medidata — Deploys RaveX 61
May 08, 2017: Medidata Introduces Regulated Content and Document Management Capabilities to Its Industry-Leading Cloud Platform 62
Apr 26, 2017: UCB Selects Medidata Clinical Cloud to Support Patient-Centric Drug Development 63
Apr 24, 2017: WuXi Clinical Development Services Expands Use of Medidata’s Cloud Technology Platform 64
Feb 01, 2017: Medidata to Expand Its Industry-Leading Cloud Platform with Regulated Content and Document Management Capabilities 65
Jan 31, 2017: Pharm-Olam International Deploys Medidata Rave; Shores up Global Data Management and Reporting Capabilities 67
Jan 12, 2017: Celgene Increases Adoption of Medidata Clinical Cloud, Gaining Further Value from Implementation of Medidata’s Strategic Monitoring and Data Analytics Solutions 68
Nov 01, 2016: Japan’s Nobelpharma Selects Medidata as Technology Partner for New Clinical Study on Sleep Disorders 69
Oct 18, 2016: LifeMap Solutions Joins Medidata AppConnect Partner Program to Drive mHealth Innovation 70
Sep 20, 2016: Polaris Pharmaceuticals Adopts Medidata Payments 71
Sep 07, 2016: Medidata and Techfields Launch mHealth Stroke Study 72
Jul 22, 2016: Medidata Cloud Technology Selected to Support Biogen Clinical Trials 73
Jul 19, 2016: Medidata Collaborates with Leading New York Cancer Center to Expand the Use of mHealth Technology in Oncology Care 74
Jun 13, 2016: Leading Korean CRO Strengthens Global R&D Capabilities by Expanding Use of Medidata’s Cloud Technology Platform 75
Mar 23, 2016: China-Based Biotech Selects Medidata Technology Platform to Simplify Complexity in Oncology R&D 76
Feb 29, 2016: Top Chinese CRO Increases Clinical Trial Productivity and Drives Innovation Across Asia with Medidata Technology 77
Jan 20, 2016: Celltrion and Medidata Team Up to Transform Global Clinical Trials for Biosimilars 78
Appendix 79
Methodology 79
About GlobalData 79
Contact Us 79
Disclaimer 79

List of Tables
Medidata Solutions Inc, Medical Equipment, Key Facts, 2016 2
Medidata Solutions Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Medidata Solutions Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Medidata Solutions Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Medidata Solutions Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Medidata Solutions Inc, Deals By Market, 2011 to YTD 2017 9
Medidata Solutions Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Syapse Raises USD30 Million in Series D Financing 12
Shyft Analytics Raises USD12.5 Million in Series B Venture Financing 14
Quartesian Enters into Licensing Agreement with Medidata Solutions 15
Medidata Expands Partnership with CytomX Therapeutics 16
Medidata Solutions Expands its Agreement with BeiGene 17
Medidata Solutions and Karyopharm Therapeutics Expand Partnership 18
Medidata Solutions Enters into Agreement with Forty Seven 19
Medidata Solutions Enters into Agreement with Memorial Sloan Kettering Cancer Center 20
Medidata Solutions Partners with C&R Research 21
Auris Medical Enters Into Agreement With Medidata Solutions 22
Veeva Systems Enters Into Technology Integration Agreement With Medidata Solutions 23
Medidata Solutions Completes Private Placement Of Notes Due 2018 For US$287.5 Million 24
Medidata Solutions Inc, Key Competitors 25
Medidata Solutions Inc, Key Employees 26
Medidata Solutions Inc, Other Locations 28
Medidata Solutions Inc, Subsidiaries 28

★海外企業調査レポート[Medidata Solutions Inc (MDSO)-医療機器分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Staatsolie Maatschappij Suriname NV：企業の戦略的SWOT分析
    Staatsolie Maatschappij Suriname NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Duke Energy Florida LLC：電力：M&Aディール及び事業提携情報
    Summary Duke Energy Florida, LLC (Duke Energy Florida), a subsidiary of Duke Energy Corporation, is a regulated public utility. It carries out the generation, transmission, distribution and sale of electricity in Florida. The company operates a diversified generation facilities utilizing coal, gas a …
  • bioLytical Laboratories Inc：企業の製品パイプライン分析
    Summary bioLytical Laboratories Inc (bioLytical) operates as a medical device company that develops and manufactures HIV diagnostic products. The company provides products such as insti HIV-1 and HIV-2 antibody test and insti HIV-1 and HIV-2 test controls. Its product line offers test result that tr …
  • Indovina Bank Ltd：企業の戦略的SWOT分析
    Indovina Bank Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Petron Corp (PCOR)：企業の財務・戦略的SWOT分析
    Petron Corp (PCOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Nihon Kohden Corporation：戦略・SWOT・企業財務分析
    Nihon Kohden Corporation - Strategy, SWOT and Corporate Finance Report Summary Nihon Kohden Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Okamoto Industries, Inc.：企業の戦略・SWOT・財務分析
    Okamoto Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Okamoto Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • MediciNova Inc (MNOV)：製薬・医療：M&Aディール及び事業提携情報
    Summary MediciNova Inc (MediciNova) focuses on acquiring, and developing novel, small-molecule therapeutics for the treatment of neurology, respiratory, and liver diseases. MediciNova’s developmental pipeline includes core programs for the treatment of fibrotic diseases; neurological disorders; and …
  • Exelon Corporation (EXC)-エネルギー分野：企業M&A・提携分析
    Summary Exelon Corporation (Exelon) is a utility services holding company operating across the energy value chain comprising power generation, distribution, transmission and energy sales. It generates electricity from diverse sources, including nuclear, fossil fuels and renewable energy. Exelon deli …
  • Primary Health Care Ltd (PRY)：企業の財務・戦略的SWOT分析
    Primary Health Care Ltd (PRY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Middlesex Water Company (MSEX)：企業の財務・戦略的SWOT分析
    Summary Middlesex Water Company (Middlesex Water) is a provider of water utility services. The company's services include water production, treatment and distribution, regulated and non-regulated water and wastewater utility services, wastewater system maintenance and working to promote economic dev …
  • Tsumura & co (4540)：企業の財務・戦略的SWOT分析
    Tsumura & co (4540) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Endesa SA (ELE)：電力：M&Aディール及び事業提携情報
    Summary Endesa SA (Endesa), a subsidiary of Enel SpA, is an electric utility. It generates, distributes, and sells electricity. The company produces electricity in hydro, thermal, nuclear, combined cycle, and renewable and cogeneration plants. Endesa also supplies electricity and gas, and provides o …
  • Ames Construction Inc：企業の戦略的SWOT分析
    Ames Construction Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Aptuit LLC：製薬・医療：M&Aディール及び事業提携情報
    Summary Aptuit LLC (Aptuit) is a developer and manufacturer of pharmaceutical drug. The company offers drug design and discovery, IND enabling programs, integrated chemistry, manufacture and control and indigo. It drug discovery capabilities includes medicinal chemistry, computational chemistry, pha …
  • Cummins Inc (CMI)-エネルギー分野：企業M&A・提携分析
    Summary Cummins Inc. (Cummins) is a manufacturer of diesel engines and related technologies. It designs, manufactures, services and distributes engines and related component solutions. The company offers filtration, fuel systems, control systems, after treatment devices, turbochargers, air handling …
  • Banco Santander SA：戦略・SWOT・企業財務分析
    Banco Santander SA - Strategy, SWOT and Corporate Finance Report Summary Banco Santander SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Compugen Ltd (CGEN)：企業の財務・戦略的SWOT分析
    Summary Compugen Ltd (Compugen) is a predictive drug discovery and development company that develops medicines for immuno-oncology and autoimmune diseases. The company’s immuno-oncology pipeline comprises COM701 and PVRIG; BAY 1905254, COM902 and TIGIT; and autoimmune diseases pipeline includes CGEN …
  • SunPower Corporation：企業の戦略・SWOT・財務情報
    SunPower Corporation - Strategy, SWOT and Corporate Finance Report Summary SunPower Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • OdontoPrev SA (ODPV3)：企業の財務・戦略的SWOT分析
    OdontoPrev SA (ODPV3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆